<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>SEN‑B Project</title>
  <style>
    body{margin:0;font-family:Arial,Helvetica,sans-serif;color:#333;background:#fdfdfd;line-height:1.6}
    header{background:#2c3e50;color:#fff;padding:1rem 0}
    .container{max-width:1200px;margin:0 auto;padding:0 1rem}
    nav ul{list-style:none;display:flex;gap:1rem;padding:0;margin:0}
    nav a{color:#fff;text-decoration:none;font-weight:bold}
    nav a:hover{opacity:.8}
    section{padding:2rem 0}
    #senb,#hep,#contact{display:none}
    .hero{display:flex;flex-wrap:wrap;gap:1rem;justify-content:center;align-items:center}
    .hero img{width:360px;max-width:100%;border-radius:8px;box-shadow:0 4px 8px rgba(0,0,0,.1)}
    footer{background:#2c3e50;color:#fff;text-align:center;padding:1rem;margin-top:2rem}
    h2{color:#2c3e50}
    h3{color:#0066a1;margin-top:1.2rem}
  </style>
  <script>
    function showSection(id){
      document.querySelectorAll('main section').forEach(s=>s.style.display='none');
      document.getElementById(id).style.display='block';
      window.scrollTo({top:0,behavior:'smooth'});
    }
    document.addEventListener('DOMContentLoaded',()=>{
      showSection('home');
    });
  </script>
</head>
<body>
  <header>
    <div class="container" style="display:flex;align-items:center;gap:0.5rem;flex-wrap:wrap">
      <img src="https://upload.wikimedia.org/wikipedia/commons/f/fd/Flag_of_Senegal.svg" alt="Flag of Senegal" style="height:24px;border-radius:2px;box-shadow:0 2px 4px rgba(0,0,0,.2)">
      <h1 style="margin:0;font-size:1.5rem">SEN‑B Project</h1>
      <nav style="margin-left:auto">
        <ul>
          <li><a href="#" onclick="showSection('home');return false;">Home</a></li>
          <li><a href="#" onclick="showSection('senb');return false;">About SEN‑B Project</a></li>
          <li><a href="#" onclick="showSection('hep');return false;">About Hepatitis B</a></li>
          <li><a href="#" onclick="showSection('contact');return false;">Contact</a></li>
        </ul>
      </nav>
    </div>
  </header>

  <main class="container">
    <!-- Home / Landing -->
    <section id="home">
      <h2>Welcome</h2>
      <p>Discover our commitment to tackling hepatitis B in Senegal through the SEN‑B cohort study.</p>
      <div class="hero">
        <!-- Single illustration provided by the user -->
        <img src="data:image/jpeg;base64,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" alt="Hepatitis B virus attacking the liver">
      </div>
    </section>

    <!-- About SEN-B Project -->
    <section id="senb">
      <h2>About the SEN‑B Project</h2>
      <p>The SEN‑B project follows a cohort of nearly 1,000 adult patients with HBV monoinfection or HIV/HBV coinfection at the Infectious and Tropical Diseases Unit (SMIT) of Fann University Hospital (CHNU) in Dakar, Senegal.</p>
      <h3>Specific Objectives</h3>
      <ul>
        <li>Evaluate eligibility for HBV antiviral treatment and monitor clinical and virological responses.</li>
        <li>Determine hepatocellular carcinoma (HCC) incidence and develop a predictive score to guide screening.</li>
        <li>Investigate intra‑hepatic histopathological determinants and validate peripheral cccDNA biomarkers.</li>
        <li>Assess knowledge and perceptions of HBV treatment through a socio‑anthropological study.</li>
        <li>Monitor SARS‑CoV‑2 seroprevalence trends among people living with HBV in the cohort.</li>
      </ul>
    </section>

    <!-- About Hepatitis B -->
    <section id="hep">
      <h2>About Hepatitis B</h2>
      <h3>Key Facts</h3>
      <ul>
        <li>Hepatitis B is a viral infection that attacks the liver and can cause acute and chronic disease.</li>
        <li>WHO estimates 254 million people were chronically infected in 2022, with 1.2 million new infections each year.</li>
        <li>In 2022, hepatitis B caused ~1.1 million deaths, mainly from cirrhosis and liver cancer.</li>
        <li>Safe and effective vaccines have been available since 1982.</li>
      </ul>

      <h3>Overview</h3>
      <p>Hepatitis B virus (HBV) can lead to rapid acute illness or long‑term chronic infection. Chronic HBV poses a significant risk of cirrhosis and hepatocellular carcinoma. The highest burden is in the Western Pacific and African regions.</p>

      <h3>Transmission</h3>
      <p>The virus is commonly transmitted perinatally, in early childhood, through unprotected sex, unsafe injections, or contact with infected blood. HBV remains infectious for at least seven days outside the body, with an incubation period of 30‑180 days.</p>

      <h3>Symptoms</h3>
      <ul>
        <li>Jaundice (yellow skin/eyes)</li>
        <li>Dark urine</li>
        <li>Extreme fatigue</li>
        <li>Nausea &amp; vomiting</li>
        <li>Abdominal pain</li>
      </ul>
      <p>Most acute infections are asymptomatic. In infants &amp; young children, HBV becomes chronic in ~95% of cases.</p>

      <h3>HBV &amp; HIV Coinfection</h3>
      <p>Roughly 1% of people with HBV are also living with HIV. Tenofovir‑based antiretroviral therapy is effective against both viruses and is recommended for all people with HIV.</p>

      <h3>Diagnosis</h3>
      <p>HBV cannot be distinguished clinically from other hepatitis viruses; laboratory tests (HBsAg, HBeAg, HBV DNA) are essential. WHO recommends routine screening of blood donations and targeted testing for high‑risk groups.</p>

      <h3>Treatment</h3>
      <p>There is no specific therapy for acute infection. Chronic HBV is managed with lifelong antivirals such as tenofovir or entecavir, slowing disease progression and reducing liver‑cancer risk.</p>

      <h3>Prevention</h3>
      <p>Universal newborn vaccination (birth dose within 24 hours, followed by 2‑3 doses) provides long‑term protection. Additional measures include safe sex, sterile injection practices, and antiviral prophylaxis in pregnancy.</p>

      <h3>WHO Response</h3>
      <p>Under the Global Health Sector Strategy on Viral Hepatitis 2022‑2030, WHO aims to eliminate hepatitis as a public‑health threat by 2030. Campaigns such as World Hepatitis Day highlight prevention, testing, and treatment.</p>
    </section>

    <!-- Contact -->
    <section id="contact">
      <h2>Contact</h2>
      <p>For further information:</p>
      <ul>
        <li>Prof. Gilles Wandeler – <a href="mailto:gilles.wandeler@unibe.ch">gilles.wandeler@unibe.ch</a></li>
        <li>Prof. Moussa Seydi – <a href="mailto:seydi.moussa@gmail.com">seydi.moussa@gmail.com</a></li>
        <li>Dr. Adrià Ramirez Mena – <a href="mailto:adrià.ramirez@posteo.net">adrià.ramirez@posteo.net</a></li>
        <li>Bintou Fall – <a href="mailto:bintoufall2298@gmail.com">bintoufall2298@gmail.com</a></li>
      </ul>
    </section>
  </main>

  <footer>
    <div class="container">© 2025 SEN‑B Project</div>
  </footer>
</body>
</html>
